- Elevance Health (ELV, Financial) showcases robust growth with significant EPS and revenue increases in Q1 2025.
- Analyst projections point towards a substantial upside, with a GF Value suggesting nearly 49% growth potential.
- The stock is rated as "Outperform" by major brokerage firms, indicating favorable market conditions.
Elevance Health (ELV) has unveiled an impressive financial performance for the first quarter of 2025. The company reported a GAAP diluted EPS of $9.61 and an adjusted EPS of $11.97, representing a remarkable year-over-year growth of over 10%. This solid performance was underpinned by operating revenue reaching $48.8 billion, driven by increased premiums and membership expansion. Additionally, Elevance Health has reaffirmed its 2025 adjusted EPS guidance, projecting a range between $34.15 and $34.85.
Wall Street Analysts Forecast
Analyzing the insights from 19 analysts, Elevance Health Inc (ELV, Financial) presents an average target price of $493.87. The highest price target is set at $585.00, while the lowest stands at $428.00. This average target indicates a potential upside of 18.21% from the current stock price of $417.77. For a more comprehensive understanding of these estimates, visit the Elevance Health Inc (ELV) Forecast page.
The investment community's consensus, drawn from 24 brokerage firms, reveals an average recommendation score of 2.1 for Elevance Health Inc (ELV, Financial), signifying its "Outperform" status. This rating is on a scale from 1 to 5, where 1 is a Strong Buy and 5 a Sell.
Evaluating GF Value
According to GuruFocus's detailed estimates, the projected GF Value for Elevance Health Inc (ELV, Financial) in the coming year is $622.26. Such a valuation implies a substantial upside potential of 48.95% from the current price of $417.77. The GF Value is a comprehensive estimation of the stock's fair trading value, calculated based on historical trading multiples, past business growth, and expected future performance metrics. For further details, explore the Elevance Health Inc (ELV) Summary page.
